FindTrial
Sign In

prospective study in diabetic patients.

Rheumatological manifestations and drug utilization study in Diabetes Mellitus.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/07/019981
Enrollment
200
Registered
2019-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients diagnosed with diabetes mellitus ( Type 1 and type 2)

Exclusion criteria

Exclusion criteria: All individuals diagnosed as Gestational Diabetes, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis

Design outcomes

Primary

MeasureTime frame
to evaluate prevalence of rheumatological manifestations among diabtes patients in tertiary care hospital in western rajasthan.Timepoint: through out the study—

Secondary

MeasureTime frame
to compare the presence of parameters of metabolic syndrome in diabetic patients with and without rheumatolic manifestations.Timepoint: through out the study;to perform drug utilization study among diabetic patients.Timepoint: through out the study—

Countries

India

Contacts

Public ContactDr Jyoti Sharma

All India Institute Of Medical Sciences Jodhpur

jenifer.raibhohra@gmail.com9873519558

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026